The Respiratory Monitors segmentation by application delineates five principal use‑cases that collectively shape market dynamics. Intensive Care Units (ICU) dominate with roughly 40% of revenue, driven by continuous ventilation monitoring, high‑risk patient turnover, and stringent regulatory compliance. Home Care accounts for about 30%, reflecting the shift toward tele‑health and chronic disease management, where portable, battery‑operated units enable long‑term compliance monitoring. Operating Rooms contribute 15%; intra‑operative ventilation control demands rapid response times and integration with anesthesia workstations, elevating unit value. Neonatal Care represents 10% of the market, as preterm infants require precise, low‑volume tidal‑volume measurement and non‑invasive monitoring to avoid lung injury. Finally, Emergency Transport holds a 5% share, where rugged, compact monitors are essential for ambulance and air‑medical services. Each segment’s share aligns with the intensity of clinical oversight required, influencing overall market size through distinct procurement cycles, reimbursement structures, and technology adoption rates.